| |
 |
|
|
Inventor: Kawakami; Hajime
Address: Nishinomiya, JP
No. of patents: 8
Patents:
| Patent Number |
Title Of Patent |
Date Issued |
| 7396842 |
Five-membered cyclic compounds |
July 8, 2008 |
| A 5-membered cyclic compound of the formula: ##STR00001## wherein X is oxygen or sulfur, R.sup.1 is hydrogen, substituted or unsubstituted alkyl, etc., R.sup.2 is hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted aryl, etc., Y.sup.1 is a direct bond, substit |
| 6951866 |
Bicyclic pyrimidine compounds and therapeutic use thereof |
October 4, 2005 |
| 1. A pyrimidine derivative of the formula (1) or a salt thereof; ##STR1##has an inhibitory activity of production of Th2 type cytokines such as IL-4, IL-5, etc., and is useful as an therapeutic agent for allergic diseases, autoimmune diseases such as systemic lupus erythemathosus, etc., |
| 6919361 |
Five-membered-ring compound |
July 19, 2005 |
| A 5-membered cyclic compound of the formula: ##STR1##wherein X is oxygen or sulfur, R.sup.1 is hydrogen, substituted or unsubstituted alkyl, etc., R.sup.2 is hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted aryl, etc., Y.sup.1 is a direct bond, substituted o |
| 6692926 |
Recombinant human SM-11044-binding receptor proteins exhibiting ligand-binding activities, and t |
February 17, 2004 |
| Transformed cells designed to express a recombinant human SMBP at an elevated level to the extent that its ligand-binding activity can be measured, and cellular membrane fractions thereof; recombinant human SMBPs isolated from the transformed cells or the cellular membrane fractions |
| 6458798 |
Bicyclic pyrimidine compounds and therapeutic use thereof |
October 1, 2002 |
| A pyrimidine derivative of the formula (1) or a salt thereof; ##STR1##has an inhibitory activity of production of Th2 type cytokines such as IL-4, IL-5, etc., and is useful as an therapeutic agent for allergic diseases, autoimmune diseases such as systemic lupus erythemathosus, etc., |
| 6329381 |
Heterocyclic compounds |
December 11, 2001 |
| The present invention relates to a heterocyclic compound of the following general formula (I): ##STR1##wherein X is sulfur atom, oxygen atom or --NR.sup.3 -- (R.sup.3 may form a heterocyclic ring or a substituted heterocyclic ring with R.sup.1 via the nitrogen atom),R.sup.1 is alkyl |
| 5948786 |
Piperidinylpyrimidine derivatives |
September 7, 1999 |
| A compound of formula (1) ##STR1## wherein X.sup.1 is amino or hydroxyl, X.sup.2 is carbonyl and the like R.sup.1 is an alkyl, an aryl and the like, R.sup.2 is hydrogen and the like, and R.sup.3 is an alkyl and the like, or a pharmaceutical acceptable salt thereof is effective fo |
| 5225422 |
Pyridine compounds which are useful as leukotriene B4 antagonist |
July 6, 1993 |
| Leukotriene B.sub.4 antagonists of the formula: ##STR1## wherein each symbol is as defined in the specification, processes for producing them, and pharmaceutical compositions containing them. The compounds of the present invention are very useful as the drugs for the treatment of |
|
|
|
